|
Name |
1-Octen-3-yl acetate
|
Molecular Formula | C10H18O2 | |
IUPAC Name* |
oct-1-en-3-yl acetate
|
|
SMILES |
CCCCCC(C=C)OC(=O)C
|
|
InChI |
InChI=1S/C10H18O2/c1-4-6-7-8-10(5-2)12-9(3)11/h5,10H,2,4,6-8H2,1,3H3
|
|
InChIKey |
DOJDQRFOTHOBEK-UHFFFAOYSA-N
|
|
Synonyms |
1-Octen-3-yl acetate; Oct-1-en-3-yl acetate; 2442-10-6; 1-OCTEN-3-OL, ACETATE; 1-Pentylallyl acetate; Amyl vinyl carbinol acetate; 3-Acetoxy-1-octene; Octenyl acetate; 3-Acetoxyoctene; Amyl vinyl carbinyl acetate; Amyl crotonyl acetate; Pentyl crotonyl acetate; 1-Octen-3-ol, 3-acetate; Pentyl vinyl carbinol acetate; FEMA No. 3582; 1-Octenyl-3-acetate; 2PZ32LCA02; MFCD00036568; 2242-10-6; 3-Acetoxy octene; 1-vinylhexyl acetate; EINECS 219-474-7; Octen-3-yl acetate; BRN 1722392; 1-Octen-3-yl-acetate; AI3-34394; oct-1-en-3-yl ethanoate; UNII-2PZ32LCA02; SCHEMBL111270; 1-OCTENE-3-OL ACETATE; DTXSID9051903; Acetic acid 1-octen-3-yl ester; CHEBI:180237; acetic acid oct-1-en-3-yl ester; CAA44210; 1-OCTEN-3-YL ACETATE [FCC]; AKOS015843186; 1-OCTEN-3-YL ACETATE [FHFI]; AM84828; BS-16234; SY015801; CS-0152332; FT-0653201; FT-0655261; O0559; 1-Octen-3-yl acetate, >=97%, FCC, FG; D71009; 4-02-00-00192 (Beilstein Handbook Reference); 442O106; A816187; A817295; W-107318; Q15927659
|
|
CAS | 2442-10-6 | |
PubChem CID | 17121 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 170.25 | ALogp: | 3.1 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 12 | QED Weighted: | 0.346 |
Caco-2 Permeability: | -4.42 | MDCK Permeability: | 0.00003080 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.006 |
30% Bioavailability (F30%): | 0.331 |
Blood-Brain-Barrier Penetration (BBB): | 0.999 | Plasma Protein Binding (PPB): | 83.81% |
Volume Distribution (VD): | 1.159 | Fu: | 28.23% |
CYP1A2-inhibitor: | 0.514 | CYP1A2-substrate: | 0.488 |
CYP2C19-inhibitor: | 0.167 | CYP2C19-substrate: | 0.871 |
CYP2C9-inhibitor: | 0.103 | CYP2C9-substrate: | 0.841 |
CYP2D6-inhibitor: | 0.015 | CYP2D6-substrate: | 0.491 |
CYP3A4-inhibitor: | 0.251 | CYP3A4-substrate: | 0.317 |
Clearance (CL): | 3.258 | Half-life (T1/2): | 0.687 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.131 |
Drug-inuced Liver Injury (DILI): | 0.17 | AMES Toxicity: | 0.213 |
Rat Oral Acute Toxicity: | 0.103 | Maximum Recommended Daily Dose: | 0.405 |
Skin Sensitization: | 0.337 | Carcinogencity: | 0.408 |
Eye Corrosion: | 0.335 | Eye Irritation: | 0.839 |
Respiratory Toxicity: | 0.724 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000849 | 0.487 | D0ZK8H | 0.333 | ||||
ENC001211 | 0.475 | D01QLH | 0.317 | ||||
ENC000529 | 0.474 | D0Y3KG | 0.289 | ||||
ENC000250 | 0.432 | D04MWJ | 0.255 | ||||
ENC002444 | 0.422 | D0AY9Q | 0.254 | ||||
ENC000652 | 0.422 | D0R3QY | 0.250 | ||||
ENC000254 | 0.400 | D0Q6DX | 0.224 | ||||
ENC000235 | 0.400 | D06FEA | 0.217 | ||||
ENC000212 | 0.396 | D0I4DQ | 0.217 | ||||
ENC000602 | 0.395 | D0Z5BC | 0.214 |